Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP822659.RA6FjvTbM_oQ4s3_VFXGaId_L42IfyVo1flqiFhUq0aXw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP822659.RA6FjvTbM_oQ4s3_VFXGaId_L42IfyVo1flqiFhUq0aXw130_assertion type Assertion NP822659.RA6FjvTbM_oQ4s3_VFXGaId_L42IfyVo1flqiFhUq0aXw130_head.
- NP822659.RA6FjvTbM_oQ4s3_VFXGaId_L42IfyVo1flqiFhUq0aXw130_assertion description "[14-3-3? attenuates RhoGDI2-induced cisplatin resistance through activation of Erk and p38 in gastric cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP822659.RA6FjvTbM_oQ4s3_VFXGaId_L42IfyVo1flqiFhUq0aXw130_provenance.
- NP822659.RA6FjvTbM_oQ4s3_VFXGaId_L42IfyVo1flqiFhUq0aXw130_assertion evidence source_evidence_literature NP822659.RA6FjvTbM_oQ4s3_VFXGaId_L42IfyVo1flqiFhUq0aXw130_provenance.
- NP822659.RA6FjvTbM_oQ4s3_VFXGaId_L42IfyVo1flqiFhUq0aXw130_assertion SIO_000772 24185104 NP822659.RA6FjvTbM_oQ4s3_VFXGaId_L42IfyVo1flqiFhUq0aXw130_provenance.
- NP822659.RA6FjvTbM_oQ4s3_VFXGaId_L42IfyVo1flqiFhUq0aXw130_assertion wasDerivedFrom befree-20150227 NP822659.RA6FjvTbM_oQ4s3_VFXGaId_L42IfyVo1flqiFhUq0aXw130_provenance.
- NP822659.RA6FjvTbM_oQ4s3_VFXGaId_L42IfyVo1flqiFhUq0aXw130_assertion wasGeneratedBy ECO_0000203 NP822659.RA6FjvTbM_oQ4s3_VFXGaId_L42IfyVo1flqiFhUq0aXw130_provenance.